Events

Professor Ken Oye (MIT) and Professor Arti Rai (Duke) will discuss the challenges and opportunities in shifting the way the US Food and Drug Administration (FDA), and its counterparts around the world, regulate pharmaceutical products. Can and should we move from a one-time decision to approve a drug in general, to a sequential process of partial approvals with continued monitoring and learning over time? How can our regulatory systems incorporate continued learning, as new technologies and their impacts emerge? This event is one in the series of "Laws that Learn" speakers. Co-sponsored by the Center for Innovation Policy at Duke Law, the Rethinking Regulation program at the Kenan Institute for Ethics, and the Nicholas Institute for Environmental Policy Solutions at Duke. Lunch will be provided. If you plan to attend, please R.S.V.P. to Amber Diaz Pearson at amber.diaz@duke.edu. For additional information, please contact Professor Jonathan Wiener at 919-613-7054.